ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,431.60
-0.04%
US Tech 100
19,168.00
0.52%
다우존스 지수
38,589.16
-0.15%
Bitcoin
66,250.76
0.09%
Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. bioAffinity Technologies Inc (BIAF)

  7. bioAffinity Technologies Inc (BIAF) 뉴스

BIAF

bioAffinity Technologies (BIAF)

bioAffinity Technologies Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:BIAF
일자시간출처헤드라인심볼기업
2024/06/1221:00Business WirebioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung TestsNASDAQ:BIAFbioAffinity Technologies Inc
2024/05/1522:15Business WirebioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory VolumesNASDAQ:BIAFbioAffinity Technologies Inc
2024/05/0221:00Business WirebioAffinity Technologies News UpdateNASDAQ:BIAFbioAffinity Technologies Inc
2024/04/2421:00Business WirebioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of GrowthNASDAQ:BIAFbioAffinity Technologies Inc
2024/04/0921:00Business WirebioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer ScreeningNASDAQ:BIAFbioAffinity Technologies Inc
2024/04/0122:49Business WirebioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:BIAFbioAffinity Technologies Inc
2024/03/0907:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFbioAffinity Technologies Inc
2024/03/0903:15PR Newswire (US)Wallachbeth Capital Announces Closing of bioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
2024/03/0902:45Business WirebioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
2024/03/0902:18Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BIAFbioAffinity Technologies Inc
2024/03/0811:57Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BIAFbioAffinity Technologies Inc
2024/03/0700:45PR Newswire (US)WallachBeth Capital Announces Pricing of BioAffinity Technologies $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
2024/03/0623:46Business WirebioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:BIAFbioAffinity Technologies Inc
2024/03/0607:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFbioAffinity Technologies Inc
2024/03/0522:00Business WirebioAffinity Technologies Reports Accelerating Sales Growth of CyPath® LungNASDAQ:BIAFbioAffinity Technologies Inc
2024/02/2122:00Business WirebioAffinity Technologies News UpdateNASDAQ:BIAFbioAffinity Technologies Inc
2024/02/0622:00Business WireMedical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board and Incorporates CyPath® Lung into Medical PracticeNASDAQ:BIAFbioAffinity Technologies Inc
2024/02/0306:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
2024/02/0306:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
2024/02/0306:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
2024/02/0306:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
2024/02/0106:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFbioAffinity Technologies Inc
2024/01/3022:00Business WirebioAffinity Technologies In The NewsNASDAQ:BIAFbioAffinity Technologies Inc
2024/01/2510:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
2024/01/2510:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
2024/01/2510:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
2024/01/2322:00Business WirebioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of CancerNASDAQ:BIAFbioAffinity Technologies Inc
2024/01/0822:00Business WirebioAffinity Technologies In the NewsNASDAQ:BIAFbioAffinity Technologies Inc
2023/12/0906:06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BIAFbioAffinity Technologies Inc
2023/12/0522:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIAFbioAffinity Technologies Inc
 검색 관련기사 보기:NASDAQ:BIAF

최근 히스토리

NASDAQ
MSFT
Microsoft
CCOM
US100
US Tech 100
NYSE
MRK
Merck
NYSE
VZ
Verizon Communications
AMEX
SPY
SPDR S&P 500
USOTC
BASFY
BASF (QX)
SPI
SP500
S&P 500
COIN
SOLUSD
Solana
NYSE
BAC
Bank of America
USOTC
RHHBY
Roche (QX)
NYSE
KO
Coca Cola
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
QQQ
Invesco QQQ Trust Series 1
FX
USDEUR
US Dollar vs Euro
CCOM
SILVER
SILVER
NASDAQ
AAPL
Apple
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유